In this subchapter:
- (1) "Anaphylaxis" means a sudden, severe, and potentially life-threatening allergic reaction that occurs when a person is exposed to an allergen.
- (2) "Epinephrine auto-injector" means a disposable medical drug delivery device that contains a premeasured single dose of epinephrine intended for use to treat anaphylaxis.
(2-a) "Epinephrine delivery system" means a medical delivery device approved by the United States Food and Drug Administration that delivers a dose of epinephrine intended for use to treat anaphylaxis, including:
- (A) an epinephrine auto-injector; and
- (B) an epinephrine nasal spray.
- (3) "Physician" means a person who holds a license to practice medicine in this state.
Added by Acts 2019, 86th Leg., R.S., Ch. 653 (S.B. 1827), Sec. 1, eff. September 1, 2019.
Acts 2025, 89th Leg., R.S., Ch. 67 (S.B. 1619), Sec. 30, eff. May 19, 2025.